ENTO logo

Entero Therapeutics (ENTO) Company Overview

Profile

Full Name:

Entero Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 11, 2016

Indexes:

Not included

Description:

Entero Therapeutics (ENTO) is a biotechnology company focused on developing innovative treatments for gastrointestinal diseases. They aim to improve patient outcomes by creating therapies that target the gut, helping to manage conditions like irritable bowel syndrome and other digestive disorders.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 31, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 18, 2023

Analyst ratings

Recent major analysts updates

Mar 15, 24 Roth MKM
Buy
Jan 3, 24 Roth MKM
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Entero Therapeutics?
  • Does Entero Therapeutics pay dividends?
  • What sector is Entero Therapeutics in?
  • What industry is Entero Therapeutics in?
  • What country is Entero Therapeutics based in?
  • When did Entero Therapeutics go public?
  • Is Entero Therapeutics in the S&P 500?
  • Is Entero Therapeutics in the NASDAQ 100?
  • Is Entero Therapeutics in the Dow Jones?
  • When was Entero Therapeutics's last earnings report?
  • When does Entero Therapeutics report earnings?
  • Should I buy Entero Therapeutics stock now?

What is the ticker symbol for Entero Therapeutics?

The ticker symbol for Entero Therapeutics is NASDAQ:ENTO

Does Entero Therapeutics pay dividends?

No, Entero Therapeutics does not pay dividends

What sector is Entero Therapeutics in?

Entero Therapeutics is in the Healthcare sector

What industry is Entero Therapeutics in?

Entero Therapeutics is in the Biotechnology industry

What country is Entero Therapeutics based in?

Entero Therapeutics is headquartered in United States

When did Entero Therapeutics go public?

Entero Therapeutics's initial public offering (IPO) was on October 11, 2016

Is Entero Therapeutics in the S&P 500?

No, Entero Therapeutics is not included in the S&P 500 index

Is Entero Therapeutics in the NASDAQ 100?

No, Entero Therapeutics is not included in the NASDAQ 100 index

Is Entero Therapeutics in the Dow Jones?

No, Entero Therapeutics is not included in the Dow Jones index

When was Entero Therapeutics's last earnings report?

Entero Therapeutics's most recent earnings report was on Nov 13, 2024

When does Entero Therapeutics report earnings?

The next expected earnings date for Entero Therapeutics is May 14, 2025

Should I buy Entero Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions